Company: LAWIL
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0000750004-25-000031
Chunk: 84

Company: Light & Wonder, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 8
Chunk 84
---
1 $1,154 $762 $(776)$(306)$835 Stock-based CompensationFor the three months ended March 31, 2025 and 2024, we recognized $27 million and $22 million, respectively, in total stock-based compensation expense under all programs. These amounts include $9 million and $8 million of stock-based compensation classified as liability awards for the three months ended March 31, 2025, and 2024, respectively.Restricted Stock UnitsA summary of the changes in RSUs outstanding under our equity-based compensation plans during the three months ended March 31, 2025 is presented below:Number of Restricted Stock UnitsWeighted Average Grant Date Fair ValueUnvested RSUs as of December 31, 20242.0 $75.49 Granted1.0 $106.48 Vested(1.0)$84.82 Cancelled(0.1)$75.94 Unvested RSUs as of March 31, 20251.9 $87.32 The weighted-average grant date fair value of RSUs granted during the three months ended March 31, 2025 and 2024 was $106.48 and $99.65, respectively. The fair value of each RSU grant is based on the market value of our common stock at 

21

the time of grant. As of March 31, 2025, we had $138 million of unrecognized stock-based compensation expense relating to unvested RSUs amortized over a weighted-average period of approximately 1.5 years. The fair value at vesting date of RSUs vested during the three months ended March 31, 2025 and 2024 was $110 million and $124 million, respectively.Share Repurchase ProgramsOn June 11, 2024, our Board of Directors approved a share repurchase program under which the Company is authorized to repurchase, from time to time through June 12, 2027, up to an aggregate amount of $1.0 billion of shares of outstanding common stock. During the three months ended March 31, 2025, we repurchased approximately 1.9 million shares of common stock under the repurchase program at an aggregate cost of $167 million (including excise tax).

(13) Income Taxes

We consider new evidence (both positive and negative) at each reporting date that could affect our view of the future realization of deferred tax assets. We